By David Shepardson WASHINGTON (Reuters) -One of the two Democratic commissioners at the U.S. Federal Trade Commission who challenged their firings by President Donald Trump said on Monday he was stepping down from the agency that enforces consumer protection and antitrust law. Alvaro Bedoya said he would step down to comply with ethics rules but …
Democratic FTC commissioner Bedoya says he will step down Read More »
By Dietrich Knauth -President Donald Trump deployed National Guard troops to California after days of protests by hundreds of demonstrators against immigration raids, saying the protests interfered with federal law enforcement and framing them as a possible “form of rebellion” against the authority of the U.S. government. Defense Secretary Pete Hegseth on Monday mobilized 700 active …
Explainer-Does US law allow Trump to send troops to quell protests? Read More »
(Reuters) -The American Pharmacists Association will withhold endorsing the U.S. Centers for Disease Control and Prevention’s latest immunization schedule, which removed the recommendation for pregnant women to receive the COVID-19 vaccine. The CDC said last month COVID-19 vaccines remain an option for healthy children when parents and doctors agree that it is needed. Health Secretary …
Pharmacy group withholds endorsing CDC’s latest vaccine recommendations Read More »
WASHINGTON (Reuters) -Republican U.S. House Representative Mark Green said on Monday that he will resign from Congress to take up an offer from the private sector after the House votes again on President Donald Trump’s sweeping tax and spending bill. “Recently, I was offered an opportunity in the private sector that was too exciting to …
Republican congressman Green to resign after tax bill vote Read More »
(Reuters) -Acadia Pharmaceuticals said on Monday that the U.S. Court of Appeals has confirmed the validity of its patent for Nuplazid, its drug for hallucinations and delusions associated with Parkinson’s disease. The decision supports a December 2023 ruling from the U.S. District Court of Delaware, ensuring the patent remains protected in Acadia’s legal battle against …
US appeals court confirms patent validity of Acadia’s Parkinson’s drug Read More »
By Humeyra Pamuk WASHINGTON (Reuters) -The U.S. State Department directed all U.S. missions abroad and consular sections to resume processing Harvard University student and exchange visitor visas after a federal judge in Boston last week temporarily blocked President Donald Trump’s ban on foreign students at the Ivy League institution. In a diplomatic cable sent on …
US State Dept resumes processing Harvard student visas after judge’s ruling Read More »
By Steve Holland and Nandita Bose WASHINGTON (Reuters) -President Donald Trump said on Monday he has no plans to discontinue Starlink at the White House but might move his Tesla off-site, following his announcement over the weekend that his relationship with Elon Musk, the billionaire CEO of both companies, was over. “I may move the …
Trump to keep Starlink at White House despite break with Elon Musk Read More »
By Valerie Volcovici WASHINGTON (Reuters) -The U.S. Environmental Protection Agency on Monday proposed approving Texas’ application to oversee its own permitting for projects to inject carbon dioxide underground, a move long sought by that state’s regulators and oil and gas companies with projects in the wings. EPA Administrator Lee Zeldin said Texas is best positioned …
EPA proposes giving Texas authority to oversee CO2 injection permits Read More »
By Raphael Satter and Humeyra Pamuk WASHINGTON (Reuters) -The U.S. State Department will use an artificial intelligence chatbot to help it select the people who will perform annual reviews of promotions and moves, according to a cable issued Monday and reviewed by Reuters. The cable said that StateChat, an in-house chatbot which works using technology …
US State Department cable says agency using AI to help staff job panels Read More »
By Chad Terhune (Reuters) -Dozens of scientists, researchers and other employees at the U.S. National Institutes of Health issued a rare public rebuke Monday criticizing the Trump administration for major spending cuts that “harm the health of Americans and people across the globe,” politicize research and “waste public resources.” More than 60 current employees sent …
NIH scientists speak out over estimated $12 billion in Trump funding cuts Read More »
